TipRanks
Advertisement
Advertisement

NVS Stock Latest News

Novartis treatment of idiopathic inflammatory myopathies gets orphan designation
The FlyNovartis treatment of idiopathic inflammatory myopathies gets orphan designation
3h ago
NVS
Novartis terminates mid-stage trial of lupus nephritis treatment, Endpoints says
PremiumThe Fly
Novartis terminates mid-stage trial of lupus nephritis treatment, Endpoints says
3d ago
NVS
SpaceX Stock Forecast: ClearBridge Fund Exits SPCX Stake in Q3 Even as Wall Street Sees 38% Upside
PremiumMarket News
SpaceX Stock Forecast: ClearBridge Fund Exits SPCX Stake in Q3 Even as Wall Street Sees 38% Upside
5d ago
MA
DIS
Novartis: Pipeline and Key Assets Seen Offsetting $20B Patent Headwind; Buy Rating Reiterated with Unchanged $150 Price Target
PremiumRatings
Novartis: Pipeline and Key Assets Seen Offsetting $20B Patent Headwind; Buy Rating Reiterated with Unchanged $150 Price Target
7d ago
NVS
Alphabet’s AI Drug Hunter Isomorphic Labs In Fundraising Talks to Hit $40B Valuation
PremiumMarket News
Alphabet’s AI Drug Hunter Isomorphic Labs In Fundraising Talks to Hit $40B Valuation
11d ago
LLY
NVS
Novartis announces FDA approval of Rhapsido for symptomatic dermographism
PremiumThe FlyNovartis announces FDA approval of Rhapsido for symptomatic dermographism
12d ago
NVS
Novartis to present data from MS portfolio with 46 abstracts at MSToronto2026
Premium
The Fly
Novartis to present data from MS portfolio with 46 abstracts at MSToronto2026
12d ago
NVS
Novartis price target lowered to $156 from $170 at Morgan Stanley
Premium
The Fly
Novartis price target lowered to $156 from $170 at Morgan Stanley
13d ago
NVS
Novartis: Buy Rating Reaffirmed, Margin Outlook Strengthens with New Launches; Price Target Unchanged at CHF 150
PremiumRatings
Novartis: Buy Rating Reaffirmed, Margin Outlook Strengthens with New Launches; Price Target Unchanged at CHF 150
14d ago
NVS
Abogen announces licensing, option agreement with Novartis
PremiumThe Fly
Abogen announces licensing, option agreement with Novartis
17d ago
NVS
Piper confident Dyne’s Zeleciment rostudirsen will win January FDA approval
PremiumThe Fly
Piper confident Dyne’s Zeleciment rostudirsen will win January FDA approval
20d ago
DYN
NVS
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
PremiumTipRanks Newswire
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
24d ago
AZN
NVS
Buy Rating Reiterated on Novartis as Diversified Pipeline Supports Medium-Term Growth; CHF 150 Price Target Unchanged
PremiumRatingsBuy Rating Reiterated on Novartis as Diversified Pipeline Supports Medium-Term Growth; CHF 150 Price Target Unchanged
25d ago
NVS
Trump Trade: U.S. announces deal with Denmark over Greenland’s security
Premium
The Fly
Trump Trade: U.S. announces deal with Denmark over Greenland’s security
28d ago
AZN
BMY
Novartis announces positive CHMP opinion for Cosentyx
Premium
The Fly
Novartis announces positive CHMP opinion for Cosentyx
1M ago
NVS
U.S. weighs allowing most pharma licensing deals with China, Reuters says
PremiumThe Fly
U.S. weighs allowing most pharma licensing deals with China, Reuters says
1M ago
AZN
BMY
Anthropic Builds San Francisco Biology Lab to Advance AI Drug Development
PremiumMarket News
Anthropic Builds San Francisco Biology Lab to Advance AI Drug Development
1M ago
BMY
NVO
Legend Biotech appoints Ingrid Zhang as CEO
PremiumThe Fly
Legend Biotech appoints Ingrid Zhang as CEO
1M ago
NVS
LEGN
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
1M ago
DYN
NKE
Midday Fly By: Oracle reports ‘beat and raise,’ Copart to buy ACV Auctions
PremiumThe FlyMidday Fly By: Oracle reports ‘beat and raise,’ Copart to buy ACV Auctions
1M ago
CL
GS
Novartis investors to increase scrutiny of company’s strategy, Reuters reports
Premium
The Fly
Novartis investors to increase scrutiny of company’s strategy, Reuters reports
1M ago
NVS
3 Best Vanguard ETFs for Reliable Dividend Income
Premium
Market News
3 Best Vanguard ETFs for Reliable Dividend Income
1M ago
JPM
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >